Noul Co

Noul Co EPS

The Earnings per Share (EPS) of Noul Co (376930.KQ) as of Oct 30, 2026 is -500.19 KRW. In the previous year, Earnings per Share (EPS) was -608.15 KRW — a change of -17.75% (higher).

EPS

-500.19KRW

YoY

-17.75%

Last updated:

Earnings per Share (EPS) of Noul Co is 2025 -500.19 KRW. Earnings per Share (EPS) of Noul Co was 2024 -608.15 KRW. It decreases by -17.75% higher compared to the previous year.

The Noul Co EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
-574.47 KRW
Jan 1, 2020
-430.37 KRW
Jan 1, 2021
-590.55 KRW
Jan 1, 2022
-597.19 KRW
Jan 1, 2023
-441.74 KRW
Jan 1, 2024
-608.15 KRW
Jan 1, 2025
-500.19 KRW
The Noul Co EPS history
YEAREPSYoY
-500.19KRW-17.75%
-608.15KRW+37.67%
-441.74KRW-26.03%
-597.19KRW+1.12%
-590.55KRW+37.22%
-430.37KRW-25.08%
-574.47KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Noul Co Stock analysis

What does Noul Co do? Noul Co., Ltd. generates revenue through the manufacture and sale of blood test diagnostic devices utilizing AI algorithms and diagnostic kits. The company offers regular monthly subscriptions via its integrated web-based remote diagnosis system, targeting healthcare providers and medical facilities seeking advanced diagnostic solutions. Its core products include AI-based diagnostic devices and associated kits, sold directly to clinics and hospitals for use in blood testing procedures. The firm's services are designed to enhance diagnostic accuracy and efficiency through remote access and subscription models. The company's primary revenue streams stem from the sale of physical diagnostic devices and diagnostic kits, alongside recurring subscription fees for its web-based remote diagnosis platform. Healthcare institutions and medical professionals form the key customer segments, purchasing both the hardware and ongoing service access. Noul Co., Ltd. focuses on delivering AI-driven diagnostic tools that integrate seamlessly into existing healthcare workflows, emphasizing convenience and technological innovation for its clients. Noul Co., Ltd. operates exclusively within the healthcare diagnostics sector, providing AI-powered blood test solutions that combine hardware sales with subscription-based software services. The business model relies on initial device purchases followed by continuous revenue from monthly subscriptions, creating a sustainable income stream. This approach ensures long-term engagement with healthcare providers while maintaining a focus on cutting-edge diagnostic technology. Noul Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Noul Co stock

Earnings per Share (EPS) of Noul Co is -500.19 KRW in 2025.

Earnings per Share (EPS) of Noul Co changed from -608.15 KRW to -500.19 KRW, representing a -17.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Noul Co since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Noul Co

All Key Metrics — Noul Co